Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invictus MD Strategies Corp (GENE.VN)

Invictus MD Strategies Corp (GENE.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,229
  • Shares Outstanding, K 124,583
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 3.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.07
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.32
  • Most Recent Earnings -0.05 on 10/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.108 on 11/17/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.030 +66.67%
on 02/14/20
0.170 -70.59%
on 01/28/20
-0.120 (-70.59%)
since 01/24/20
3-Month
0.030 +66.67%
on 02/14/20
0.190 -73.68%
on 01/24/20
-0.060 (-54.55%)
since 11/25/19
52-Week
0.030 +66.67%
on 02/14/20
1.090 -95.41%
on 02/28/19
-0.920 (-94.85%)
since 02/25/19

Most Recent Stories

More News
Invictus Obtains Further Court Approvals in Connection with CCAA Proceedings

(the "") announces that on Monday, February 24, 2020, the Supreme Court of British Columbia (the "") granted an amended and restated initial order (the "") under the (Canada) (""). The Amended and Restated...

GENE.VN : 0.050 (unch)
IVITF : 0.0125 (-16.67%)
IIROC Trading Resumption - GENE

VANCOUVER , Feb. 14, 2020 /CNW/ - Trading resumes in:

GENE.VN : 0.050 (unch)
Cannabis Stocks Are "No Place to Put Your Money" Reviewers Warn

USA News Group - While it may appear very enticing to jump in on the legalization of cannabis by investing in the sector, leading reviewers are coming out strong against putting your money in pot stocks....

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
CXXI.CN : 0.485 (-4.90%)
CXXIF : 0.3711 (-3.56%)
BE.CN : 0.005 (unch)
BLEVF : 0.0040 (+11.11%)
ICNB : 0.4900 (+2.94%)
INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
Invictus MD Strategies Corp. Opens the Market

TORONTO , Aug. 19, 2019 /CNW/ - Trevor Dixon , Chief Executive Officer, Invictus MD Strategies Corp. (GENE), joined Steven Mills, Head, Company Services, Toronto Stock Exchange and TSX Venture...

GENE.VN : 0.050 (unch)
ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
Savvy Investors Seek out Innovative Cannabis Opportunities

The booming cannabis industry has created opportunities for many driven entrepreneurs. In particular, many may be looking to launch something standard such as operating a retail dispensary or starting...

STZ : 172.87 (+0.83%)
BKLLF : 0.0570 (-0.70%)
CODE.CN : 0.070 (unch)
IGC : 0.6394 (-5.97%)
CBWTF : 0.1789 (-0.56%)
XLY.VN : 0.240 (unch)
CNAB : 0.0165 (-65.63%)
IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)
Invictus announces Annual General Meeting Results

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.0125 (-16.67%)
GENE.VN : 0.050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.070
1st Resistance Point 0.060
Last Price 0.050
1st Support Level 0.045
2nd Support Level 0.040

See More

52-Week High 1.090
Fibonacci 61.8% 0.685
Fibonacci 50% 0.560
Fibonacci 38.2% 0.435
Last Price 0.050
52-Week Low 0.030

See More

Business Summary

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar